A Multicenter Trial Evaluating Retaspimycin HCL (IPI-504) Plus Trastuzumab in Patients with Advanced or Metastatic HER2-positive Breast Cancer

Reshma Mahtani; Shanu Modi; Cristina Saura; Charles Henderson; Nancy U Lin; Jill Goddard; Eduardo Rodenas; Clifford Hudis; Joyce A. O'Shaughnessy; Jose Baselga

A Multicenter Trial Evaluating Retaspimycin HCL (IPI-504) Plus Trastuzumab in Patients with Advanced or Metastatic HER2-positive Breast Cancer

Reshma Mahtani
, Shanu Modi
, Cristina Saura
, Charles Henderson
, Nancy U Lin
, Jill Goddard
, Eduardo Rodenas
, Clifford Hudis
, Joyce A. O'Shaughnessy
, Jose Baselga

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Breast cancer research and treatment
Volume	139
State	Published - Apr 12 2013

Disciplines

Medicine and Health Sciences

Cite this

@article{bd4200f327b5465a93b33fdab87529f8,

title = "A Multicenter Trial Evaluating Retaspimycin HCL (IPI-504) Plus Trastuzumab in Patients with Advanced or Metastatic HER2-positive Breast Cancer",

author = "Reshma Mahtani and Shanu Modi and Cristina Saura and Charles Henderson and Lin, \{Nancy U\} and Jill Goddard and Eduardo Rodenas and Clifford Hudis and O'Shaughnessy, \{Joyce A.\} and Jose Baselga",

note = "Heat shock protein 90 (Hsp90) facilitates maturation and stability of HER2. Combining an Hsp90 inhibitor and trastuzumab has demonstrated anti-tumor effects in patients with HER2+ breast cancer. Adults with measurable, locally advanced or metastatic HER2+ breast cancer and prior trastuzumab treatmen ...",

year = "2013",

month = apr,

day = "12",

language = "American English",

volume = "139",

journal = "Breast cancer research and treatment",

}

TY - JOUR

T1 - A Multicenter Trial Evaluating Retaspimycin HCL (IPI-504) Plus Trastuzumab in Patients with Advanced or Metastatic HER2-positive Breast Cancer

AU - Mahtani, Reshma

AU - Modi, Shanu

AU - Saura, Cristina

AU - Henderson, Charles

AU - Lin, Nancy U

AU - Goddard, Jill

AU - Rodenas, Eduardo

AU - Hudis, Clifford

AU - O'Shaughnessy, Joyce A.

AU - Baselga, Jose

N1 - Heat shock protein 90 (Hsp90) facilitates maturation and stability of HER2. Combining an Hsp90 inhibitor and trastuzumab has demonstrated anti-tumor effects in patients with HER2+ breast cancer. Adults with measurable, locally advanced or metastatic HER2+ breast cancer and prior trastuzumab treatmen ...

PY - 2013/4/12

Y1 - 2013/4/12

UR - https://pubmed.ncbi.nlm.nih.gov/23580070/

M3 - Article

VL - 139

JO - Breast cancer research and treatment

JF - Breast cancer research and treatment

ER -

A Multicenter Trial Evaluating Retaspimycin HCL (IPI-504) Plus Trastuzumab in Patients with Advanced or Metastatic HER2-positive Breast Cancer

Disciplines

Other files and links

Cite this